Molecular Templates Announces Dosing of First Patient in Phase 1 Expansion Study of MT-3724 in Diffuse Large B-Cell Lymphoma (DLBCL) Oct 24, 2017 8:52am EDT
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences Sep 22, 2017 1:54pm EDT
Molecular Templates to Present at the BioCentury 24th Annual Newsmakers in the Biotech Industry Conference Sep 06, 2017 2:17pm EDT
Molecular Templates to Present at the 2017 Wedbush PacGrow Healthcare Conference Aug 14, 2017 8:00am EDT
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements Aug 02, 2017 8:30am EDT
Molecular Templates Announces Presentations Featuring Engineered Toxin Bodies at the 2017 American Association for Cancer Research (AACR) Annual Meeting Mar 30, 2017 4:01pm EDT
Molecular Templates to Present Clinical and Preclinical Data for MT-3724 and Next Generation Engineered Toxin Bodies (ETBs) at the 2016 American Association for Cancer Research (AACR) Annual Meeting Apr 06, 2016 8:30am EDT
Molecular Templates Collaborates with the MD Anderson Cancer Center on Research of MT-3724 in Chemo-Resistant Aggressive B-Cell Lymphomas Oct 08, 2015 8:30am EDT
